These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 1905501)

  • 81. [Present position in the prevention and therapy of NSAID-induced ulcers].
    Lehmann FS; Beglinger C
    Schweiz Med Wochenschr; 1999 Jul; 129(29-30):1073-80. PubMed ID: 10464910
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Sulglycotide in the prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal mucosal injury. A controlled double-blind, double-dummy, randomized endoscopic study versus placebo in rheumatic patients.
    Bianchi Porro G; Montrone F; Petrillo M; Caruso I; Ardizzone S
    Scand J Gastroenterol; 1993 Oct; 28(10):875-8. PubMed ID: 8266016
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Misoprostol reduces gastroduodenal injury from one week of aspirin: an endoscopic study.
    Jiranek GC; Kimmey MB; Saunders DR; Willson RA; Shanahan W; Silverstein FE
    Gastroenterology; 1989 Feb; 96(2 Pt 2 Suppl):656-61. PubMed ID: 2491827
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Role of misoprostol in reducing aspirin-induced gastrointestinal blood loss in arthritic patients.
    Ryan JR; Vargas R; Clay GA; McMahon FG
    Am J Med; 1987 Jul; 83(1A):41-6. PubMed ID: 3113245
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum.
    Lanza FL; Aspinall RL; Swabb EA; Davis RE; Rack MF; Rubin A
    Gastroenterology; 1988 Aug; 95(2):289-94. PubMed ID: 3134266
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Prevention of NSAID-associated gastroduodenal injury in healthy volunteers-a randomized, double-blind, multicenter study comparing DA-9601 with misoprostol.
    Lee KN; Lee OY; Choi MG; Choi SR; Lee DH; Lee YC; Kim TN; Choi SC; Rew JS; Seol SY
    J Korean Med Sci; 2011 Aug; 26(8):1074-80. PubMed ID: 21860559
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
    Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI
    N Engl J Med; 1996 May; 334(22):1435-9. PubMed ID: 8618582
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Prevention of NSAID-gastropathy.
    Ardizzone S; Bianchi Porro G
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():33-6. PubMed ID: 9032581
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Prevention of NSAID-induced gastric ulcer with prostaglandin analogues.
    Rietbrock N; Karim A; Nicholson PA
    Lancet; 1989 Apr; 1(8642):844-5. PubMed ID: 2564928
    [No Abstract]   [Full Text] [Related]  

  • 90. Prostaglandin E1 (misoprostol) overcomes the adverse effect of chronic cigarette smoking on duodenal ulcer healing.
    Lam SK; Lau WY; Choi TK; Lai CL; Lok AS; Hui WM; Ng MM; Choi SK
    Dig Dis Sci; 1986 Feb; 31(2 Suppl):68S-74S. PubMed ID: 3080292
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Misoprostol: a prostaglandin E1 analogue.
    Garris RE; Kirkwood CF
    Clin Pharm; 1989 Sep; 8(9):627-44. PubMed ID: 2507215
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Misoprostol: a prostaglandin E1 analog with antisecretory and cytoprotective properties.
    Jones JB; Bailey RT
    DICP; 1989 Apr; 23(4):276-82. PubMed ID: 2499129
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Healing of NSAID-induced gastric ulcers with a synthetic prostaglandin analog (enprostil).
    Sontag SJ; Schnell TG; Budiman-Mak E; Adelman K; Fleischmann R; Cohen S; Roth SH; Ipe D; Schwartz KE
    Am J Gastroenterol; 1994 Jul; 89(7):1014-20. PubMed ID: 8017358
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
    Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Misoprostol in the treatment of duodenal ulcer. A multicenter double-blind placebo-controlled study.
    Sontag SJ; Mazure PA; Pontes JF; Beker SG; Dajani EZ
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):159S-163S. PubMed ID: 3932049
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Misoprostol treatment exacerbates abdominal discomfort in patients with non-ulcer dyspepsia and erosive prepyloric changes. A double-blind, placebo-controlled, multicentre study.
    Hausken T; Stene-Larsen G; Lange O; Aronsen O; Nerdrum T; Hegbom F; Schulz T; Berstad A
    Scand J Gastroenterol; 1990 Oct; 25(10):1028-33. PubMed ID: 2124724
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Treatment of peptic ulcer induced by non-steroidal anti-inflammatory drugs.
    Malchow-Møller A
    Scand J Gastroenterol Suppl; 1987; 127():87-91. PubMed ID: 3303297
    [TBL] [Abstract][Full Text] [Related]  

  • 98. NSAID gastropathy, misoprostol, and the standard of care.
    Plumeri PA
    J Clin Gastroenterol; 1990 Aug; 12(4):470-4. PubMed ID: 2118926
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Double-blind comparison of two dosage regimens of misoprostol in the treatment of duodenal ulceration.
    Birnie GG; Watkinson G; Shroff NE; Akbar FA
    Dig Dis Sci; 1988 Oct; 33(10):1269-73. PubMed ID: 3139379
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A report of three multiclinic trials evaluating arbaprostil in arthritic patients with ASA/NSAID gastric mucosal damage. The Upjohn Company Arbaprostil ASA/NSAID Gastric Mucosal Damage Treatment Study Groups.
    Euler AR; Safdi M; Rao J; Jaszewski R; Welsh J; Le V; Raskin J; Fleischmann R; Razzaque M; Champion C
    Gastroenterology; 1990 Jun; 98(6):1549-57. PubMed ID: 2186951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.